Elotuzumab
(NEW) CAR T-Cell Therapies: Idecabtagene Vicleucel and Ciltacabtagene Autoleucel
Selinexor
(NEW) Teclistamab-cqyv
NCCN Virtual Reimbursement Resource Room
Multiple Myeloma Research Foundation (MMRF)
ASH: COVID-19 Resources for Managing Blood Cancers
JNCCN: How To Manage Cancer Care During COVID-19 Pandemic